Shares of SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) fell 1.2% during trading on Thursday . The company traded as low as $24.38 and last traded at $24.38. 200 shares traded hands during trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Trading Down 1.2 %
The stock has a market cap of $6.64 billion, a P/E ratio of 48.76, a PEG ratio of 1.30 and a beta of 1.81. The stock’s fifty day moving average price is $24.38 and its 200 day moving average price is $24.38.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Featured Stories
- Five stocks we like better than SWEDISH ORPHAN/S
- Investing In Automotive Stocks
- 3 Leveraged ETFs to Multiply Returns
- Compound Interest and Why It Matters When Investing
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Want to Profit on the Downtrend? Downtrends, Explained.
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
